What are the recommended treatments for migraines in the third trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Migraines in the Third Trimester of Pregnancy

Paracetamol (acetaminophen) is the first-line medication for acute treatment of migraine during the third trimester of pregnancy, with a recommended dose of 1000 mg. 1

First-Line Treatment Options

  • Paracetamol (acetaminophen) is the safest and preferred first-line pharmacological treatment for migraine attacks during the third trimester due to its established safety profile in pregnancy 1, 2
  • Non-pharmacological approaches should always be implemented alongside medication, including:
    • Maintaining adequate hydration 1
    • Following regular meal schedules 1
    • Ensuring sufficient and consistent sleep patterns 1
    • Engaging in appropriate physical activity 1
    • Identifying and avoiding personal migraine triggers 1

Second-Line Treatment Options

  • Metoclopramide can be used for nausea associated with migraine, particularly in the third trimester 1, 3
  • Sumatriptan may be considered for sporadic use under strict specialist supervision when other treatments fail to provide adequate relief 1, 4
  • NSAIDs such as ibuprofen should be avoided during the third trimester due to risks of premature closure of the ductus arteriosus and other complications 1, 4

Medications to Avoid in Third Trimester

  • Opioids and butalbital-containing medications should not be used due to risks of dependency, rebound headaches, and potential harm to the fetus 1, 5
  • Ergot alkaloids (including dihydroergotamine) are contraindicated during pregnancy 1, 6
  • CGRP antagonists (gepants) should be avoided due to insufficient safety data in pregnancy 1
  • Topiramate, candesartan, and sodium valproate are contraindicated due to known adverse effects on the fetus 1

Preventive Treatment Considerations

  • Preventive medications should only be considered in cases of frequent and severely disabling migraine attacks that are unresponsive to acute treatments 1, 7
  • If preventive therapy is absolutely necessary:
    • Propranolol has the best available safety data and is the first choice for preventive therapy 1, 3
    • Amitriptyline can be used if propranolol is contraindicated or ineffective 1, 7
  • Regular monitoring is essential when using any preventive medications during pregnancy 1

Important Clinical Considerations

  • Medication overuse headache can occur with frequent use of acute medications (≥15 days/month with NSAIDs; ≥10 days/month with triptans) 1
  • The majority of women experience improvement in migraine symptoms during pregnancy, particularly in the second and third trimesters 2, 3
  • Treatment decisions should balance the risks of inadequately treated severe migraine (which can lead to dehydration, poor nutrition, and stress) against potential medication risks 4
  • Postpartum, many women experience a recurrence of migraines, likely due to hormonal fluctuations 2

Treatment Algorithm for Third Trimester Migraine

  1. Start with non-pharmacological approaches for all patients 1
  2. For mild to moderate attacks: paracetamol 1000 mg 1
  3. For inadequate response: add metoclopramide for associated nausea 1, 3
  4. For severe, refractory attacks: consider sumatriptan under specialist supervision 1, 4
  5. For frequent, disabling attacks: consider preventive therapy with propranolol or amitriptyline 1, 7

References

Guideline

Migraine Management During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Migraine in pregnancy.

Neurology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Migraine therapy during pregnancy and lactation.

Expert opinion on drug safety, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.